Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

788
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
788
Cancer Prevention02:59

Cancer Prevention

8.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilates Method as a complementary activity reduces myofascial stiffness and pain in women with breast cancer undergoing aromatase inhibitor therapy: a randomized controlled trial.

Scientific reports·2026
Same author

First-line durvalumab in combination with trastuzumab deruxtecan in women with locally advanced unresectable or metastatic, hormone-receptor-negative, HER2-low breast cancer: multicenter, open-label, phase 1b/2 BEGONIA platform trial.

Nature cancer·2026
Same author

Durvalumab Plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Advancing Systemic Treatment beyond First Line for Advanced Hepatocellular Carcinoma.

Current oncology reports·2026
Same author

Pituitary carcinoma: a diagnostic labyrinth in a rare endocrinopathy.

Endokrynologia Polska·2026
Same author

Mutational landscapes of brain metastases across various histological subtypes of lung cancer.

Lung cancer (Amsterdam, Netherlands)·2026

Related Experiment Video

Updated: Feb 20, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K

Prospects for implementing the European Code of Cancer Practice: Lessons from Poland.

Joanna Kufel-Grabowska1, Jacek Jassem1

  • 1Department and Clinic of Oncology and Radiotherapy, Medical University of Gdańsk, Poland.

Health Policy (Amsterdam, Netherlands)
|February 18, 2026
PubMed
Summary

Implementing the European Code of Cancer Practice (ECCP) in Poland faces barriers like staff shortages and unequal access. Addressing these requires workforce, organizational, and cultural changes for better cancer care equity.

Keywords:
Cancer care equityCancer patient rightsCancer policy implementationEuropean Code of Cancer PracticeHealth system barriersPolandQuality of cancer care

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.2K
Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
05:18

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

11.8K

Related Experiment Videos

Last Updated: Feb 20, 2026

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.2K
Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
05:18

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

11.8K

Area of Science:

  • Oncology
  • Health Services Research
  • Patient Rights

Background:

  • The European Code of Cancer Practice (ECCP) outlines ten patient rights to enhance cancer care equity, quality, and patient-centeredness.
  • National implementation data for the ECCP, especially in Central and Eastern Europe, is scarce.

Purpose of the Study:

  • To evaluate the perceived feasibility of implementing the European Code of Cancer Practice (ECCP) within Poland.
  • Assessing national readiness for ECCP adoption to identify implementation challenges and opportunities.

Main Methods:

  • A 2024 cross-sectional online survey distributed to Polish oncology specialists and psycho-oncologists.
  • Feasibility of each ECCP right was rated on a 5-point Likert scale, supplemented by thematic analysis of free-text comments.

Main Results:

  • 225 specialists provided feasibility ratings; 345 submitted comments. Rights perceived as most feasible included access to information, shared decision-making, and priority discussions.
  • Significant challenges were identified in achieving equal access to optimal care, structured survivorship/rehabilitation planning, and multidisciplinary team care.
  • Key barriers reported were staff shortages, insufficient consultation time, disparities in diagnostic/therapeutic access, and prevailing cultural attitudes.

Conclusions:

  • Successful ECCP implementation in Poland necessitates overcoming workforce, organizational, and cultural obstacles.
  • Priorities for improvement include establishing a national clinical trial registry, enhancing multidisciplinary units, and bolstering rehabilitation, palliative care, and communication training.
  • Proposed actions are deemed feasible and potentially transferable to other European healthcare systems.